1. researcher17
2. lakehome45
3. ggordon100
4. SPICKS100
5. umberjacques
1.umberjacques 10/17/2017
Top Analyst likes it....
2.researcher17 09/25/2017
long haul individuals, long haul. Disregard the reality administration dumped shares a week ago and around 18% prior
3.ggordon100 09/25/2017
would you be able to present at a meeting if your organization's stock cost was down just about 20%
4.lakehome45 09/25/2017
Hard couple of days
5.lakehome45 02/07/2018
Announces updated data from expansion cohorts in a phase 1 trial of cabozantinib in combination with either …
6.researcher17 10/17/2017
Positive study results and regulatory news and still could not hold onto gains. Maybe consolidation for a while? {Image}
7.lakehome45 10/17/2017
NEWS: Exelixis Rockets To 17-Year High On Kidney, Liver Cancer News
8.researcher17 03/15/2018
Company has completed the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug…
9.SPICKS100 05/17/2018
Exelixis partner Ipsen
10.ggordon100 02/13/2018
Announces results from Phase 2
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW